Titre:
  • Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group.
Auteur:Lutz, Manfred B.; Van Cutsem, Eric; Wagener, Theo; Van Laethem, Jean-Luc; Vanhoefer, Udo; Wils, Jaques; Gamelin, Eric; Koehne, Claus H; Arnaud, Jean-Pierre; Mitry, Emmanuel; Husseini, Fares; Reichardt, Peter; El-Serafi, Mustafa; Etienne, Pierre-Luc; Lingenfelser, Thomas; Praet, Michel; Genicot, Bruno; Debois, Muriel; Nordlinger, Bernard; Ducreux, Michel; European Organisation for Research and Treatment of Cancer Gastrointestinal Group,
Informations sur la publication:Journal of clinical oncology, 23, 36, page (9250-9256)
Statut de publication:Publié, 2005-12
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Carcinoma -- drug therapy -- pathology
Cisplatin -- administration & dosage
Deoxycytidine -- administration & dosage -- analogs & derivatives
Disease Progression
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Pancreatic Neoplasms -- drug therapy -- pathology
Survival Analysis
Taxoids -- administration & dosage
Note générale:Clinical Trial, Phase II
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2005.02.1980
info:pii/23/36/9250
info:pmid/16361622